METACOST - Observational Study on the management of HER2-positive breast cancer with brain metastases and its associated costs

Head :
Leclerc-Zwirn Christel, Laboratoire GSK

Last update : 09/07/2020 | Version : 1 | ID : 156

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Observational Study on the management of HER2-positive breast cancer with brain metastases and its associated costs
Sign or acronym METACOST
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation CNIL : 1410836
General Aspects
Medical area Cancer research
Keywords breast, oncology, metastasis, retrospective, cost
Scientific investigator(s) (Contact)
Name of the director Leclerc-Zwirn
Surname Christel
Phone +33 (0)1 39 17 86 96
Email christel.c.leclerc-zwirn@gsk.com
Unit Laboratoire GSK
Collaborations
Funding
Funding status Private
Details GSK laboratory
Governance of the database
Sponsor(s) or organisation(s) responsible Laboratoire GSK
Organisation status Private
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Longitudinal study (except cohorts)
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Selection in each center (via PMSI and the DIM (medical information department) doctor of the investigating center) of a list of potentially eligible patients (patients who have had breast cancer with SNC metastases between 2006 and 2008). The presence or not of an overexpression of the HER2 status is then codes by the oncologist.
Database objective
Main objective Describe the medical care of patients who have one or several secondary brain metastases to a primary breast cancer overexpressing HER2 and evaluate the cost of this from a health insurance standpoint
Inclusion criteria • Patients from breast cancer with brain metastase(s)
• with overexpressing the HER2 receptor
• with brain metastases diagnosed between January 1, 2006 and December 31, 2008
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Gender Woman
Geography area National
Detail of the geography area France
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2010
Date of last collection (YYYY or MM/YYYY) 2011
Size of the database
Size of the database (number of individuals) < 500 individuals
Details of the number of individuals 220
Data
Database activity Data collection completed
Type of data collected Clinical data
Biological data
Administrative data
Clinical data (detail) Direct physical measures
Biological data (detail) Histology of the tumor, mitotic index and presence of specific receptors (estrogens, progesterone, HER2)
Administrative data (detail) PMSI (GHM, drugs)
Presence of a biobank No
Health parameters studied Health event/morbidity
Health event/mortality
Health care consumption and services
Care consumption (detail) Hospitalization
Medical/paramedical consultation
Medicines consumption
Procedures
Data collection method Filling out e-CRFs by a CRA of the CRU of the investigating center in collaboration with the oncologist.
Participant monitoring Yes
Details on monitoring of participants 6 months, 12 months, 18 months and 24 months
Links to administrative sources Yes
Linked administrative sources (detail) PMSI
Promotion and access
Promotion
Access
Terms of data access (charter for data provision, format of data, availability delay) Publications
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05